{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:18:31Z","timestamp":1792988311143,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":90,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.berh.2024.101939","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:07:48Z","timestamp":1710403668000},"page":"101939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0657-485X","authenticated-orcid":false,"given":"Elena","family":"Elefante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.berh.2024.101939_bib1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","article-title":"Guidelines for referral and management of systemic lupus erythematosus in adults. American college of rheumatology ad hoc committee on systemic lupus erythematosus guidelines","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2024.101939_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.md.0000147737.57861.7c","article-title":"Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature","volume":"83","author":"Boddaert","year":"2004","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.berh.2024.101939_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2024.101939_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"9","key":"10.1016\/j.berh.2024.101939_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a lupus low disease activity state (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2024.101939_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/rheumatology\/key349","article-title":"The relationship between remission and health-related quality of life in a cohort of SLE patients","volume":"58","author":"Tsang-A-Sjoe","year":"2019","journal-title":"Rheumatology"},{"issue":"14","key":"10.1016\/j.berh.2024.101939_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1177\/0961203310377090","article-title":"Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001--2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study)","volume":"19","author":"Tamayo","year":"2010","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/ken477","article-title":"Employment and work disability in systemic lupus erythematosus: a systematic review","volume":"48","author":"Baker","year":"2009","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2024.101939_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0961203313477227","article-title":"Depression and systemic lupus erythematosus: a systematic review","volume":"22","author":"Palagini","year":"2013","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/art.24347","article-title":"Work disability in systemic lupus erythematosus","volume":"61","author":"Al Dhanhani","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2024.101939_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.10512","article-title":"Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores","volume":"47","author":"Alarc\u00f3n","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2024.101939_bib13","first-page":"1967","article-title":"Determinants of discordance between patients and physicians in their assessment of lupus disease activity","volume":"30","author":"Yen","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2024.101939_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13075-020-02334-5","article-title":"Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus","volume":"22","author":"Elefante","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2024.101939_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0961203309345748","article-title":"Discordant assessment of lupus activity between patients and their physicians: the Singapore experience","volume":"19","author":"Leong","year":"2010","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0961203317722412","article-title":"Discordance of patient and physician health status concerns in systemic lupus erythematosus","volume":"27","author":"Golder","year":"2018","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.berh.2024.101939_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0961203317749746","article-title":"Individuals living with lupus: findings from the LUPUS UK Members Survey 2014","volume":"27","author":"Morgan","year":"2018","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.berh.2024.101939_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000469","article-title":"Living with systemic lupus erythematosus in 2020: a European patient survey","volume":"8","author":"Cornet","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.berh.2024.101939_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001133","article-title":"Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus","volume":"6","author":"Elefante","year":"2020","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40744-021-00328-6","article-title":"Patient experiences, satisfaction, and expectations with current systemic lupus erythematosus treatment: results of the SLE-UPDATE survey","volume":"8","author":"Birt","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"2","key":"10.1016\/j.berh.2024.101939_bib21","article-title":"Systemic lupus erythematosus: state of the art on clinical practice guidelines","volume":"4","author":"Tamirou","year":"2018","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.berh.2024.101939_bib22","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/rheumatology\/keab534","article-title":"Medication decision-making and adherence in lupus: patient-physician discordance and the impact of previous \u201cadverse medical experiences.\u201d","volume":"61","author":"Sloan","year":"2022","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2024.101939_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/acr.23794","article-title":"A novel system to categorize the symptoms of systemic lupus erythematosus","volume":"71","author":"Pisetsky","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/acr.24135","article-title":"Using clinical characteristics and patient-reported outcome measures to categorize systemic lupus erythematosus subtypes","volume":"73","author":"Rogers","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/rheumatology\/ken479","article-title":"Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort","volume":"48","author":"Chambers","year":"2009","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2024.101939_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00296-018-4016-2","article-title":"Physician-patient communication in rheumatology: a systematic review","volume":"38","author":"Georgopoulou","year":"2018","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.berh.2024.101939_bib27","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2009.117200","article-title":"European League against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies","volume":"69","author":"Mosca","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2024.101939_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2010.12.008","article-title":"Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice","volume":"10","author":"Mosca","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.berh.2024.101939_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/0961203310366572","article-title":"Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus","volume":"19","author":"Nossent","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101939_bib30","unstructured":"Treat-to-target in systemic lupus erythematosus: Where are we? - PubMed [Internet]. [cited 2023 May 1]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32014364\/.."},{"issue":"2","key":"10.1016\/j.berh.2024.101939_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10067-018-4286-9","article-title":"Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study","volume":"38","author":"Fasano","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2024.101939_bib32","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3899\/jrheum.190223","article-title":"Treat-to-target endpoint definitions in systemic lupus erythematosus: more is less?","volume":"46","author":"Morand","year":"2019","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101939_bib33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2024.101939_bib34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0961203312441980","article-title":"Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective","volume":"21","author":"Gallop","year":"2012","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.berh.2024.101939_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.rdc.2016.01.001","article-title":"Patient-reported outcomes in systemic lupus erythematosus","volume":"42","author":"Mahieu","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"issue":"11","key":"10.1016\/j.berh.2024.101939_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103188","article-title":"Do biological agents improve health-related quality of life in patients with systemic lupus erythematosus? Results from a systematic search of the literature","volume":"21","author":"Gomez","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.berh.2024.101939_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101939_bib38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/art.41598","article-title":"Long-term safety and efficacy of Anifrolumab in adults with systemic lupus erythematosus: results of a phase II open-label extension study","volume":"73","author":"Chatham","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2024.101939_bib39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/annrheumdis-2021-221425","article-title":"Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials","volume":"81","author":"Vital","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2024.101939_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/acr.23734","article-title":"Patient-reported outcomes predict mortality in lupus","volume":"71","author":"Azizoddin","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101939_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1092325","article-title":"EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus","volume":"9","author":"Lindblom","year":"2022","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.berh.2024.101939_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","article-title":"Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus","volume":"27","author":"Schmeding","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"Suppl5","key":"10.1016\/j.berh.2024.101939_bib43","doi-asserted-by":"crossref","first-page":"v63","DOI":"10.1093\/rheumatology\/keaa427","article-title":"The patient\u2019s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?","volume":"59","author":"Kernder","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101939_bib44","unstructured":"https:\/\/www.lupus-europe.org\/wp-content\/uploads\/2018\/10\/Patient-Panel-project-report-Excl-confidential-elements.pdf. In.."},{"issue":"Supplement 1","key":"10.1016\/j.berh.2024.101939_bib45","first-page":"2","article-title":"OP0004 - lupus 100.org \u2013 a step change in access to quality information for European lupus patients","volume":"82","author":"Karakikla-Mitsakou","year":"2023","journal-title":"EULAR Congress"},{"issue":"4","key":"10.1016\/j.berh.2024.101939_bib46","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/rheumatology\/kes370","article-title":"Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature","volume":"52","author":"Castelino","year":"2013","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2024.101939_bib47","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.23013","article-title":"Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status","volume":"57","author":"Stamm","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422400010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422400010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:53:15Z","timestamp":1718826795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169422400010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S152169422400010X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101939","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101939"}}